These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
25. Safety of intravenous immunoglobulin in the treatment of juvenile dermatomyositis: adverse reactions are associated with immunoglobulin A content. Manlhiot C; Tyrrell PN; Liang L; Atkinson AR; Lau W; Feldman BM Pediatrics; 2008 Mar; 121(3):e626-30. PubMed ID: 18299304 [TBL] [Abstract][Full Text] [Related]
26. The evaluation of suspected immune deficiency by the primary care physician. Infante AJ; Kamani NR Compr Ther; 1997 Feb; 23(2):89-94. PubMed ID: 9083718 [No Abstract] [Full Text] [Related]
27. [Problems in the use of intravenously administered immunoglobulin]. Martin TD Ter Arkh; 1996; 68(10):83-8. PubMed ID: 9026956 [No Abstract] [Full Text] [Related]
28. [The use of intravenous 7S immunoglobulins at high doses in HIV-related immunological pathology]. Fiori GP Clin Ter; 1994 Apr; 144(4):301-5. PubMed ID: 8205754 [TBL] [Abstract][Full Text] [Related]
30. Polyclonal immunoglobulins for intravenous use induce interleukin 10 release in vivo and in vitro. Lories RJ; Casteels-Van Daele M; Ceuppens JL; Van Gool SW Ann Rheum Dis; 2004 Jun; 63(6):747-8. PubMed ID: 15140788 [No Abstract] [Full Text] [Related]
32. Subcutaneous administration of IgG. Berger M Immunol Allergy Clin North Am; 2008 Nov; 28(4):779-802, viii. PubMed ID: 18940574 [TBL] [Abstract][Full Text] [Related]
33. [Treatment of patients with primary antibody deficiencies in Germany]. Borte M; Oertelt C; Högy B Klin Padiatr; 2005; 217(5):276-80. PubMed ID: 16167275 [TBL] [Abstract][Full Text] [Related]
34. [Intravenous immunoglobulin (Endobulin) clinical tolerance: prospective therapeutic follow-up of 142 adults and children]. Pautard B; Hachulla E; Bagot d'Arc M; Chantreuil L Rev Med Interne; 2003 Aug; 24(8):505-13. PubMed ID: 12888171 [TBL] [Abstract][Full Text] [Related]
35. Resolution of warts in association with subcutaneous immunoglobulin in immune deficiency. Lin JH; Wang KY; Kraft S; Roberts RL Pediatr Dermatol; 2009; 26(2):155-8. PubMed ID: 19419461 [TBL] [Abstract][Full Text] [Related]
36. [Polyvalent immunoglobulins in prevention of viral infections in children with neoplastic diseases treated with immunosuppressive therapy]. Graf N; Hille A; Jost W; Müller J Padiatr Padol; 1991; 26(4):187-91. PubMed ID: 1749627 [TBL] [Abstract][Full Text] [Related]
37. Anti-HIV antibodies in patients receiving intravenous immunoglobulin. Bloom RD; Triglia D; Asser S Ann Allergy; 1988 Jul; 61(1):30-4. PubMed ID: 3133965 [TBL] [Abstract][Full Text] [Related]
38. Treatment of selective antibody deficiency with IVIG resulting in decreased frequency of streptococcal infection and improvement of guttate psoriasis. Dhandha MM; Siegfried EC; Knutsen AP Dermatol Online J; 2017 Aug; 23(8):. PubMed ID: 29469743 [TBL] [Abstract][Full Text] [Related]
39. Adverse reactions of prophylactic intravenous immunoglobulin infusions in Iranian patients with primary immunodeficiency. Aghamohammadi A; Farhoudi A; Nikzad M; Moin M; Pourpak Z; Rezaei N; Gharagozlou M; Movahedi M; Atarod L; Afshar AA; Bazargan N; Hosseinpoor AR Ann Allergy Asthma Immunol; 2004 Jan; 92(1):60-4. PubMed ID: 14756466 [TBL] [Abstract][Full Text] [Related]
40. [Treatment of severe acute disseminated encephalomyelitis with intravenous immunoglobulin]. Andersen JB; Paerregaard A; Herning GM; Pedersen SA Ugeskr Laeger; 2000 May; 162(22):3197-9. PubMed ID: 10850212 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]